Juvenile Arthritis Quantitative Imaging
NCT02684695 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2018-05-02
Summary
This observational study aims to develop and validate quantitative magnetic resonance imaging biomarkers as measures of disease activity in juvenile idiopathic arthritis (JIA). This includes patients with enthesitis-related arthritis (ERA).
Conditions
- Arthritis, Juvenile Idiopathic
- Enthesitis-Related Arthritis, Juvenile
Interventions
- OTHER
-
MRI scan (adolescent spine protocol)
MRI scan of the lumbar spine and sacroiliac joints
- OTHER
-
MRI scan (whole body protocol)
MRI scan of multiple joints ('whole body')
Sponsors & Collaborators
-
University College London Hospitals
lead OTHER
Eligibility
- Min Age
- 12 Years
- Max Age
- 24 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2021-01-31
- Completion
- 2026-01-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis
NCT00361634 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)
NCT03780959 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Patient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference
NCT02524340 ·Status: COMPLETED
-
Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RA
NCT04078191 ·Status: TERMINATED ·Phase: PHASE2
-
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
NCT02418442 ·Status: RECRUITING
-
Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis
NCT03781375 ·Status: TERMINATED ·Phase: PHASE3
-
Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA
NCT05246280 ·Status: TERMINATED ·Phase: PHASE3
-
Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis
NCT02030613 ·Status: COMPLETED ·Phase: NA
-
Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
NCT00078793 ·Status: COMPLETED
-
Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
NCT00962741 ·Status: COMPLETED ·Phase: PHASE3
-
Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis
NCT01287715 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis
NCT04585711 ·Status: WITHDRAWN ·Phase: PHASE1
-
The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients
NCT01948388 ·Status: COMPLETED ·Phase: PHASE4
-
Juvenile Rheumatoid Arthritis Research Registry
NCT00090571 ·Status: COMPLETED
-
Advanced Therapeutics in Rheumatoid Arthritis (RA)
NCT03976245 ·Status: RECRUITING ·Phase: PHASE4
-
Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
NCT01421069 ·Status: COMPLETED ·Phase: PHASE3
-
Novel Quantitative MRI for Axial Spondyloarthritis
NCT03778515 ·Status: TERMINATED
-
Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients
NCT02476084 ·Status: COMPLETED
-
Empowering Physicians With Evidence-Based Decision Support for Pediatric Rheumatology
NCT02205086 ·Status: UNKNOWN ·Phase: NA
-
Study of Methotrexate Given to Juvenile Idiopathic Arthritis Patients Based on Pharmacogenomics and Pharmacometrics
NCT03006991 ·Status: UNKNOWN
-
Study of the Safety of Orencia in Japanese Children and Adolescents With Active Juvenile Arthritis of Unknown Origin
NCT03466814 ·Status: COMPLETED
-
Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)
NCT01230177 ·Status: COMPLETED
-
PBR28 PET and Inflammatory Arthritis
NCT02361385 ·Status: COMPLETED
-
ARTEMIS Synovial Markers in Arthritis Childhood
NCT02505828 ·Status: COMPLETED ·Phase: NA
-
Scintigraphy for Prediction In Rheumatoid Intentional Therapy Tapering
NCT05983848 ·Status: NOT_YET_RECRUITING